MULTIPLE MYELOMA: CLINICAL AND EPIDEMIOLOGICAL Head-to-head longitudinal comparison of two mass spectrometry-based methods for monitoring monoclonal proteins in multiple myeloma: Analytical and clinical insights from the GEM-CESAR trial